Patents by Inventor Kirk J. Wojno

Kirk J. Wojno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETECTING PROSTATE CANCER
    Publication number: 20230280346
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer
    Type: Application
    Filed: February 20, 2023
    Publication date: September 7, 2023
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Methods of detecting prostate cancer
    Patent number: 11585814
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: February 21, 2023
    Assignee: IMMUNIS.AI, INC.
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • METHODS OF DETECTING PROSTATE CANCER
    Publication number: 20200318201
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer
    Type: Application
    Filed: April 20, 2020
    Publication date: October 8, 2020
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Methods of detecting prostate cancer
    Patent number: 10626464
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: April 21, 2020
    Assignee: Cell MDX, LLC
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Methods of detecting cancer
    Patent number: 10494675
    Abstract: This invention provides a set of biological markers that are useful for detecting cancer. This invention further provides methods of using those biological markers for the diagnosis, prognosis, or monitoring of cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: December 3, 2019
    Assignee: Cell MDX, LLC
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno